Avandia to be Pulled From U.S. Retail Pharmacies
Eight months after the U.S. Food and Drug Administration (FDA) announced it would significantly limit the use of blockbuster diabetes drug Avandia, the Agency has decided to take even further regulatory action.With the first ruling, Avandia was no longer prescribed for new patients unless their physician certified that other medications and interventions were not working. The new rules, which go into effect November 18, state that Avandia will no longer be sold at retail pharmacies and will only be available to patients who:
- Could not successfully control their blood sugar with other medications
- Have been informed of the risks and still decide to take it
- Have been “safely” using the drug
But while the steep heart risks came to light publicly just a few years back, the drug’s maker may have known of the risks for more than a decade — since 1999. As the New York Times revealed last year, a study by SmithKline conducted in 1999 found that Avandia was more dangerous to the heart than a competing drug, Actos.
But despite the negative results, SmithKline chose not to post the findings or submit them to the FDA.
The good news is that many people may be spared a future heart attack now that Avandia will be essentially blacklisted. You deserve to restore your health, not risk it with potentially toxic drugs. And you can often do just that — become free of drugs, blood sugar worries, even get off insulin and reverse type 2 diabetes — when you are able to identify the underlying causative factors of your condition, and address them with a customized treatment plan.
U.S. News & World Report May 19, 2011
To get a free copy of our Report that explains how to reverse and eliminate Type II Diabetes call 630-718-0555.
